Combating Counterfeit Drugs: Saving Lives, Saving Money

Fake goods account for nearly 10 percent of global trade, and their estimated worth is around $500 billion. Out of these, luxury items ‒ such as footwear, watches, apparel, etc. ‒ and pharmaceutical drugs are the most counterfeited across the world. Inarguably, the counterfeiting of all these categories causes irreparable damage to brands worldwide. However, it is counterfeit pharmaceutical drugs, worth more than $75 billion in 2010, which actually claim lives.
Read “Demystifying Track & Trace,” and learn how a single-source provider can help to ensure the safety of pharmaceutical drugs by:

• Ensuring that all goods (including raw materials) are recorded electronically
• Enabling serialization once these raw materials are converted to finished packed goods
• Connecting the database server to a network in order to authenticate the genuineness of the final product

The essence of practices like serialization and track & trace, along with steadily unfolding worldwide regulations, is to eliminate the counterfeiting of drugs. This is not only because pharmaceutical companies lose millions of dollars to counterfeiters, but also because a counterfeited drug could result in the loss of thousands of lives. Download this whitepaper and discover some of the solutions a single-source provider can bring when combating the problem of counterfeit drugs in the pharmaceutical industry.

Please Register

If you are already a registered user of Pharma Evolution, please login to access this content without re-entering your information.